Literature DB >> 21287178

[Thrombophilic and systemic risk factors in patients with retinal vein occlusion].

C Kuhli-Hattenbach1, W Miesbach, I Scharrer, L-O Hattenbach.   

Abstract

Over the past years there has been a dramatic increase in the number of identifiable causes of thrombophilia. However, as retinal vein occlusions (RVO) have a strong pathogenic correlation with the presence of hypertension or arteriosclerosis and the average age of affected patients is usually within the sixth or seventh decade of life, thrombophilia screening of RVO patients poses a particularly difficult diagnostic challenge. It is clear that to use medical resources appropriately and improve the level of interdisciplinary patient care in RVO, subgroup analysis is required. Just recently, some studies have demonstrated the significant role of coagulation disorders in specific subgroups of RVO patients and have provided recommendations for clinical practice. These results indicate that thrombophilic risk factors are significantly more prevalent among patients equal or less than 45 years of age at the time of RVO or a previous thromboembolic event, among patients with a remarkable family history of thromboembolism prior to the age of 45 years, or among patients without cardiovascular risk factors. According to these data, thrombophilia screening should be considered in these selected subgroups.

Entities:  

Mesh:

Year:  2011        PMID: 21287178     DOI: 10.1007/s00347-010-2289-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  31 in total

1.  Is factor XII deficiency related to recurrent miscarriage?

Authors:  T Matsuura; T Kobayashi; T Asahina; N Kanayama; T Terao
Journal:  Semin Thromb Hemost       Date:  2001       Impact factor: 4.180

2.  Heparin cofactor II deficiency in central retinal vein occlusion.

Authors:  L O Hattenbach; C Klais; I Scharrer
Journal:  Acta Ophthalmol Scand       Date:  1998-12

Review 3.  Inherited thrombophilia: Part 1.

Authors:  D A Lane; P M Mannucci; K A Bauer; R M Bertina; N P Bochkov; V Boulyjenkov; M Chandy; B Dahlbäck; E K Ginter; J P Miletich; F R Rosendaal; U Seligsohn
Journal:  Thromb Haemost       Date:  1996-11       Impact factor: 5.249

4.  Recurrence rate after a first venous thrombosis in patients with familial thrombophilia.

Authors:  Carla Y Vossen; Isobel D Walker; Peter Svensson; Juan C Souto; Inge Scharrer; F Eric Preston; Gualtiero Palareti; Ingrid Pabinger; Felix J M van der Meer; Mike Makris; Jordi Fontcuberta; Jacqueline Conard; Frits R Rosendaal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06-23       Impact factor: 8.311

5.  Retinal vascular occlusion and deficiencies in the protein C pathway.

Authors:  K Greiner; G Hafner; B Dick; D Peetz; W Prellwitz; N Pfeiffer
Journal:  Am J Ophthalmol       Date:  1999-07       Impact factor: 5.258

6.  Activated protein C resistance--low incidence in glaucomatous optic disc haemorrhage and central retinal vein occlusion.

Authors:  S L Graham; I Goldberg; B Murray; P Beaumont; B H Chong
Journal:  Aust N Z J Ophthalmol       Date:  1996-08

Review 7.  [Retinal vein occlusions].

Authors:  S Dithmar; L L Hansen; F G Holz
Journal:  Ophthalmologe       Date:  2003-07       Impact factor: 1.059

8.  Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion.

Authors:  Claudia Kuhli; Inge Scharrer; Frank Koch; Christian Ohrloff; Lars-Olof Hattenbach
Journal:  Am J Ophthalmol       Date:  2004-03       Impact factor: 5.258

9.  Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1996-05

10.  Defective thrombus formation in mice lacking coagulation factor XII.

Authors:  Thomas Renné; Miroslava Pozgajová; Sabine Grüner; Kai Schuh; Hans-Ulrich Pauer; Peter Burfeind; David Gailani; Bernhard Nieswandt
Journal:  J Exp Med       Date:  2005-07-11       Impact factor: 14.307

View more
  3 in total

1.  [Bilateral simultaneous central retinal vein occlusion in protein S deficiency].

Authors:  G Tóth; G L Sándor; C Reichel; G Domján; Z Z Nagy; M Ecsedy
Journal:  Ophthalmologe       Date:  2015-11       Impact factor: 1.059

2.  [Multiple thrombophilic risk markers in patients ≺65 years of age with retinal vein occlusion].

Authors:  C Kuhli-Hattenbach; P Hellstern; W Miesbach; T Kohnen; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2017-12       Impact factor: 1.059

3.  [Intravitreal treatment of patients with branch retinal vein occlusion depending on the duration of macular edema].

Authors:  M Rehak; E Spies; M Scholz; P Wiedemann
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.